We exist to help pharma teams get to the truth - and make it useful.
Our Founding Principle
MediSights was founded on a simple observation: in oncology and rare diseases, pharma teams are drowning in data but starving for truth they can actually trust and use.
Doctors say one thing in surveys. Behavioral data suggests another. Insights sit in static decks that arrive months late. Teams can't verify the evidence behind recommendations. And no one can prove whether their strategies actually changed anything.
The research problem no one was solving
Pharma invests billions developing breakthrough therapies for cancer and rare diseases. But when it comes time to understand how doctors actually think about those therapies, the industry is stuck with two bad options:
Wait 8 months for traditional research that's rigorous but arrives too late. Or use fast analytics tools that give you answers you can't verify or trust.
We built MediSights to give pharma teams a third option.
Deep, clinically grounded doctor intelligence—delivered fast, with full evidence traceability, and built for pharma compliance from day one.
How we do it
We capture what oncologists and rare disease specialists really think and do through deep, AI-powered conversations at scale. Then we organize that intelligence into evidence-linked insights your teams can explore, verify, and activate immediately.
Every finding links back to the underlying doctor conversation. No black boxes. No month-long wait times. No blind trust required.
Why it matters
In therapy areas where evidence evolves rapidly, treatment decisions involve complex trade-offs, and commercial windows are narrow, speed without rigor isn't helpful. Neither is rigor without speed. MediSights delivers both: clinically grounded doctor intelligence in weeks instead of months, with every insight traceable back to the source conversation.
Brand & Insights Teams
We are the oncology and rare diseases data and insights platform. We don't try to be everything to everyone. We go deep in the therapy areas where complexity, speed, and trust matter most.
We help pharma teams discover the truth, move it to where work happens, and prove it changed something.